Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/26/2003CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1406223A Protease inhibitor and their pharmaceutical uses
03/26/2003CN1406140A Nano capsule encapsulation system and method
03/26/2003CN1406137A Caspase activated prodrugs therapy
03/26/2003CN1406136A Novel antibody with specificity for colon cancer
03/26/2003CN1406131A Sympathetic-activating perfume composition
03/26/2003CN1406130A Veterinary compositions for the treatment of parasitic diseases
03/26/2003CN1406129A Methods for the treatment of substance abuse
03/26/2003CN1406128A Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
03/26/2003CN1406127A Thiazolium compounds and treatments of disorders associated with protein aging
03/26/2003CN1406126A New sustained release oral formulations
03/26/2003CN1406125A Method for transdermal or intradermal delivery of molecules
03/26/2003CN1406123A Skin normalizing agents
03/26/2003CN1406111A Nutritional formulation containing prebiotic substances
03/26/2003CN1405187A Cucurbitacin cyclodextin inclusion compound and preparation thereof
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1405179A Novel antitumor compound Philinopside B from striped pseudo-manatee
03/26/2003CN1405178A Novel anti-tumor compound Intercedenside B from picolour zhuopianshen
03/26/2003CN1405177A Rabdosia lophanthide extractive, natural medicine for treating hepatitis
03/26/2003CN1405175A C60 glucocorticoid and it use
03/26/2003CN1405168A Tert-butoxy carbonyl dihydro artemisinin, preparation method and drug composition thereof
03/26/2003CN1405164A Corter pseudolaricis acid derivatives, preparation method and use thereof
03/26/2003CN1405162A C7 ester-substituted taxane
03/26/2003CN1405157A Novel diazo alcoholic antifungal compound and its salt
03/26/2003CN1405152A Anti-tumor 2-amino-carboyl-1,2-di (methylsulfonyl)-1-(substituted) diazane
03/26/2003CN1405144A 由海龙科动物提取的海龙素及其制法和用途 Dragon species extracted by Dragon hormone preparation and use
03/26/2003CN1405139A Triterpenoid, its preparation method and drug composition using the same as active component
03/26/2003CN1405127A Nitrogenous group conversion method
03/26/2003CN1404854A Medicine for treating nosal inflammation
03/26/2003CN1404840A Anti-HIV medicine zidovudine powder injection and its preparation method thereof
03/26/2003CN1404839A Notoginseng total saponin oral liquor
03/26/2003CN1404838A Sodium fructose-diphosphate oral liquor for treating liver disease
03/26/2003CN1404837A Natural oral liquor for treatment of women's climacteric syndrome
03/26/2003CN1404836A Use of Aiben sodium phosphonate as effective component of medicine for preventing and treating osteoporosis
03/26/2003CN1404835A Composition for repairing and promoting regeneration of gastrointestinal tract mucous tissue and its preparation method thereof
03/26/2003CN1404834A Antibiotics composition with synergistic effect to generation of beta lactamase medicine-resisting strain
03/26/2003CN1404833A 药物组合物 The pharmaceutical composition of
03/26/2003CN1404832A Gliclazide oral tablet capable of quickly disintegrating and dissolving out and its preparation technology
03/26/2003CN1404831A Use of Radix scutellariae glycoside in preparing medicine for treating prostatic disorders and its medicinal composition
03/26/2003CN1404830A Method for preparing controllable complex of taxiol and polylactic acid
03/26/2003CN1404829A Double inhibitor synthesized by wax ester and cholesterol ester for inbibiting generation of sebum
03/26/2003CN1404828A Use of pantethine sulfonic acid and/or its salt as free radical scavenger
03/26/2003CN1404827A 硫普罗宁制剂 Tiopronin preparations
03/26/2003CN1404826A Method for preparing naproxen sodium release tablet
03/26/2003CN1404825A Novel decanoy acetaldelzy sodium intravenous preparation and its preparing method thereof
03/26/2003CN1404824A Transdermal absorbing composition containing tumor radiotherapy sensitive-increasing agent
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103780C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/26/2003CN1103774C Imino-aza-anthracyclinone derivatives for the theatment of amyloidosis
03/26/2003CN1103773C 二氮杂萘衍生物 Naphthyridine derivative
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103770C Quino xaline diones
03/26/2003CN1103766C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
03/26/2003CN1103762C Novel 1-ar (alk) yl-imidazolin-2-ones contg. a disubstituted amine radical in the 4th position having an anti-convulsive effect, and production method thereof
03/26/2003CN1103760C 1,3-dihydro-2H-imidazol-2-one derivatives having PDEIV and cytokinin inhibiting activity
03/26/2003CN1103756C Estrogenic agents
03/26/2003CN1103755C Novel structural analogues of vitamin D
03/26/2003CN1103601C Release-controlled somatotropin composition and method for preparation thereof
03/26/2003CN1103600C Medicinal composition of treating asthma and pulmonary hypertension
03/26/2003CN1103593C Synergistic composition
03/26/2003CN1103592C Medicinal composition containing 2-(benzylimino)-3-benzyl-1,3-hydrothiazine and its application and preparation method
03/26/2003CN1103591C Medicinal composition of substituted 1,4,5,6-tetrahydro-diazin-[4,5-c] diazine-5-tone compounds and its application and preparation method
03/26/2003CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM
03/26/2003CN1103589C Method for modulating human sexual response
03/26/2003CN1103588C Calcium complex of 4-(4-ethoxybenzyl)-3,6,9-tris (carboxylatomethyl)-3,6,9-triazaundecanedioic acid and its salt, pharmaceutical agents containing these complexes
03/26/2003CN1103586C Sucrose ester C20-28 alcohol formulations
03/26/2003CN1103544C Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals
03/26/2003CA2423902A1 Benzodiazepine derivative
03/26/2003CA2405378A1 Stable taurolidine electrolyte solutions
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003WO2002026260A1 Preventives/remedies for emotional disorders
03/25/2003US6538174 Animal model for transplantation
03/25/2003US6538155 Cleaning compounds for animal ears
03/25/2003US6538151 X-ray diffractogram reflections not coinciding with others; anticonvulsants, analgesics, antipyretics,
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538144 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use
03/25/2003US6538123 Vaccine composition for preventing or treating hepatitis C
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538116 For therapy of inflammatory or painful disorder
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
03/25/2003US6538038 A method of treating a warm-blooded animal having a vascular proliferative disorder, comprising administering, to the animal, an amount of a prodrug of a tubulin binding agent, other than combretastatin A4 disodium phosphate to achieve
03/25/2003US6538037 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder
03/25/2003US6538036 Method for preventing and treating peripheral neuropathy by administering selegiline
03/25/2003US6538035 And treatment of Chronic Obstructive Pulmonary Disease and allergic rhinitis
03/25/2003US6538034 Methods of treating or preventing weight gain, obesity, and related disorders
03/25/2003US6538032 Phytosphingosine derivatives with antitumor activity
03/25/2003US6538031 Method of controlling sea lice infestation in fish
03/25/2003US6538030 Treating radiation fibrosis
03/25/2003US6538029 Methods for treatment of renal cell carcinoma
03/25/2003US6538026 A composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl
03/25/2003US6538025 Aminoindan derivatives
03/25/2003US6538024 Felbamate derived compounds
03/25/2003US6538023 Therapeutic uses of green tea polyphenols for sickle cell disease
03/25/2003US6538022 Three-dimensional structure of the cytosolic domain of phospholamban (PLB) and its active site from NMR data of sufficiently high resolution for the three-dimensional structure determination. rational drug design enabling the
03/25/2003US6538021 Method for producing luteolin and luteolin derivatives
03/25/2003US6538020 Paclitaxel formulation
03/25/2003US6538019 Produce emulsions containing a material that are insoluble or that have low solubility with respect to water and oil in a high concentration, so as to obtain emulsions which can be preserved for a long period of time. More specifically,
03/25/2003US6538018 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
1 ... 5525 5526 5527 5528 5529 5530 5531 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 5545 ... 7860